| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.42 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.23 | 0.2 |